Qube Research & Technologies (QRT)
BIOT

Qube Research & Technologies (QRT)’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BIOT Stock Details BIOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-179,720
Closed -$1.77M – 3310
2022
Q1 		$1.77M Buy
+179,720
New +$1.77M 0.02% 860

Other funds holding BIOT

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
CM
Cohanzick Management Pleasantville, New York $231K AUM 3.17% 1-Year Est. Return
RA
RiverPark Advisors New York $219M AUM 14.91% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BIOT Position: Q2 2022 in Review

Qube Research & Technologies (QRT) sold out of Biotech Acquisition Company Class A Ordinary Shares (BIOT) in Q2 2022, closing a stake of 179,720 shares — an estimated $1.77M sold.

Qube Research & Technologies (QRT) first reported a position in BIOT in Q1 2022 and held it in 1 quarter. The position peaked at $1.77M in Q1 2022. 67 funds tracked by Wall St. Rank hold BIOT as of Q2 2022.

  • Qube Research & Technologies (QRT) reported no remaining Biotech Acquisition Company Class A Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 179,720 Biotech Acquisition Company Class A Ordinary Shares shares in Q2 2022, an estimated $1.77M.
  • Qube Research & Technologies (QRT) first reported a position in Biotech Acquisition Company Class A Ordinary Shares in Q1 2022 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Biotech Acquisition Company Class A Ordinary Shares position peaked at $1.77M in Q1 2022.
  • 67 funds tracked by Wall St. Rank held Biotech Acquisition Company Class A Ordinary Shares as of Q2 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2022, filed 15 Aug 2022.